In the last decade, immunology has evolved from a niche discipline to the very foundation of modern medicine.
From checkpoint inhibitors and CAR-T therapy to mRNA vaccines and rapid immunodiagnostics, the immune system is no longer a mystery, it is the new frontier.
The global immunology market is projected to exceed USD 216 billion by 2030 [source], driven by breakthroughs in diagnostics, vaccines, and cell-based therapeutics.
And in India, that momentum is visible — in premier institutions like AIIMS, IISc, IIT Bombay, and THSTI, where researchers are advancing translational immunology, host-pathogen biology, and affordable diagnostics.
This is why IMMUNOCON 2025, the annual conference of the Indian Immunology Society (IIS), is such a defining event.
It is where the country’s best minds — from academia, research, and biopharma come together to shape the future of immune science.
What makes IMMUNOCON 2025 different?
Unlike most scientific conferences that focus on a narrow niche, IMMUNOCON bridges the entire immunology ecosystem.
The 2025 edition (November 19–22) brings together international researchers, early-career scientists, biotech innovators, and industry partners to exchange ideas that drive discovery.
Here’s why this year’s edition stands out:
1️⃣ Global Science, Local Innovation
The conference will feature over 40 scientific sessions covering:
• Cancer Immunology & Immunotherapy
• Mucosal and Autoimmune Immunology
• Infectious Disease & Host-Pathogen Interactions
• Computational Immunology & Systems Vaccinology
• Advances in Immunodiagnostics and Biomarkers
Speakers include leading immunologists like:
• Prof. Bali Pulendran, Stanford University — Systems Vaccinology and Immune Memory
• Prof. Rahul Purwar, IIT Bombay — India’s pioneering CAR-T Cell Therapy researcher
• Prof. Peter Katsikis, Erasmus MC, Netherlands — Neoantigen Vaccination & T-cell Function
• Dr. Suman Chakraborty, IIT Kharagpur — Point-of-care diagnostic devices for low-resource settings
Their work collectively represents the cutting edge of immune engineering, translational research, and diagnostic innovation.
2️⃣ Where Academia Meets Application
IMMUNOCON 2025 is not only about research, it is about how that research becomes reality.
The conference creates a rare dialogue between academia and industry, from assay development to bioprocessing and biomarker validation.
For research institutions, it is a chance to discover technologies that simplify workflows and enhance reproducibility.
For companies like ours, it is an opportunity to showcase how validated reagents and custom solutions help accelerate discovery.
3️⃣ An Ecosystem for Young Researchers
One of IMMUNOCON’s greatest strengths is its mentorship focus.
Early-career researchers and PhD scholars gain exposure to senior scientists from IISc, ICMR, IITs, and global research centers.
Sessions like “Next-Gen Immunology: Challenges and Opportunities” and “Women in Science Leadership” make it a holistic academic experience.
For young immunologists, this is where visibility begins — and collaborations start.
Role of Diagnostics & Reagents in Immunology
In every immunology experiment — whether studying cytokine responses, vaccine efficacy, or immune cell signaling — the quality of reagents determines the quality of results.
A study published in Nature Methods found that up to 36% of reproducibility issues in life sciences stem from reagent variability [source].
And in immunology, where assays depend on high-affinity antibody-antigen interactions, reproducibility is everything.
That’s where partners like deNOVO Biolabs play a pivotal role.
How deNOVO engineers reliability for Immunology?
deNOVO Biolabs specializes in developing and validating biomolecules and assay reagents designed for reproducibility, accuracy, and confidence in data.
Our capabilities extend across the immunology and diagnostics spectrum:
1. Recombinant Proteins & Antigens
Produced using advanced expression systems to ensure correct folding, stability, and antigenicity — vital for immune response assays.
2. Validated Monoclonal Antibody Pairs
Optimized for sandwich ELISAs and lateral flow assays, tested against clinically positive samples for maximum reliability.
3. Bioprocess Monitoring Reagents
Including E. coli HCP, CHO DNA, and E. coli DNA detection kits — ensuring product purity and regulatory compliance in biologics manufacturing.
4. Custom Cell Culture Media
Formulated for consistent cell performance, validated for sterility, osmolality, and pH control — minimizing experimental variability.
5. High-Sensitivity ELISA Reagents & Buffers
Including our Super Sensitive TMB Substrate, enabling low background and high signal assays for immunological studies.
At IMMUNOCON 2025, deNOVO will showcase how our products support immunology labs in achieving reproducible results — from fundamental research to translational diagnostics.
IMMUNOCON 2025 theme x deNOVO’s Mission
I. Immunodiagnostics & Biomarker Discovery
deNOVO’s validated antibody pairs empower diagnostic researchers to quantify key immune biomarkers like cytokines, CRP, and HBsAg with unmatched precision.
II. Cellular & Molecular Immunology
Our custom media and ELISA tools enable consistent cell-based assays — essential for immune cell functional studies and vaccine trials.
III. Translational Immunology & Therapeutic Development
With bioprocess monitoring reagents, deNOVO supports therapeutic developers ensuring regulatory-grade purity in biologic products.
Impact of reliable tools in Immunology research
Reliability improves data and accelerates discovery.
When your cell cultures, antibodies, and ELISA reagents behave predictably, your focus shifts from troubleshooting to understanding biology.
That’s what IMMUNOCON celebrates — science that scales from bench to bedside.
According to Frontiers in Immunology, global publication output in immunology has grown by 42% in the past five years, reflecting unprecedented collaboration and innovation [source].
But such rapid progress depends on data that can be trusted — and trusted data begins with reliable reagents.
Why attend IMMUNOCON 2025?
IMMUNOCON isn’t just another academic event — it’s a collaborative ecosystem.
Here’s what makes attending worth it:
✅ Networking with Global Thought Leaders
Build connections with researchers, clinicians, and biotech founders shaping immunological science.
✅ Exposure to Cutting-Edge Technologies
Learn about new immunodiagnostic tools, bioprocess innovations, and AI-driven immune analytics.
✅ Real-World Problem Solving
Discuss translational challenges and co-develop new project ideas with industry collaborators.
✅ Showcasing Indian Scientific Excellence
Celebrate indigenous research and manufacturing that’s setting global standards.
For deNOVO, this event is an opportunity to not just exhibit products — but to contribute to the dialogue on data reliability and diagnostic innovation.
Key Takeaways for Researchers
• Understand emerging immunodiagnostic trends from leading scientists.
• Discover tools and reagents designed to improve assay reproducibility.
• Connect with global experts to initiate collaborative research projects.
• Gain early insight into novel biomarkers and immune modulation pathways.
• Visit our booth to explore validated solutions for your immunology workflows.
📅 Dates: November 19–22, 2025
📍 Venue: MNNIT, Allahabad, India
🌐 Event Website: www.immunocon2025.com
🎪 Visit deNOVO Biolabs: Stall #13
Let’s Build Reliability into Immunology
Whether you are studying immune signaling, developing diagnostics, or validating therapeutic candidates — your data deserves reliability.
Visit deNOVO Biolabs at IMMUNOCON 2025 (Stall #13) to explore validated reagents, custom assay solutions, and collaborative opportunities.
For more info, email us at info@denovobiolabs.com